Evidence map›Paper›PMID 21052977›Full record

ArticleDiabetologia2011

Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.

Y Wang, Y Nakagawa, L Liu, W Wang, X Ren, A Anghel, K Lutfy, T C Friedman, Y Liu

Open access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals.The Journal of clinical endocrinology and metabolism · 2021
    Trial
  2. Article
  3. Article
  4. Alterations in glucocorticoid homeostasis following sleeve gastrectomy.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Association of increased renalJournal of clinical biochemistry and nutrition · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Y WangDivision of Endocrinology, Metabolism & Molecular Medicine, Charles Drew University of Medicine & Sciences, UCLA School of Medicine, 1731 E 120th St, Los Angeles, CA 90059, USA.
Y Nakagawa
L Liu
W Wang
X Ren
A Anghel
K Lutfy
T C Friedman
Y Liu
Charles R. Drew University of Medicine and Science · USUniversity of California, Los Angeles · USHamamatsu University School of Medicine · JPShanghai Sixth People's Hospital · CN

Funding

Sustaining Faculty Development & Community EngagementS21MD000103 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI CARLISLE, DAVID M · 2001 to 2015
$73.9M
The Role of H6PDH and 11beta-HSD1 in Type 2 Diabetes and ObesitySC1DK087655 · NIDDK · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI LIU, YANJUN · 2009 to 2013
$1.6M
Genes and Proteins Leading to AddictionR01DA014659 · NIDA · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI FRIEDMAN, THEODORE C · 2002 to 2006
$1.1M
The Role of 11beta-HSD1 in Type II Diabetes and ObesityK01DK073272 · NIDDK · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI LIU, YANJUN · 2006 to 2008
$397k
STRUCTURAL DETERMINANTS IN REGULATION OF POMC PROCESSINGK21DA000276 · NIDA · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI FRIEDMAN, THEODORE C · 1995 to 1999
–
NIDA NIH HHS K21 DA00276NIDA NIH HHS R01 DA014659NIDA NIH HHS R01 DA14659NIDDK NIH HHS C1DK087655NIDDK NIH HHS K01 DK073272NIDDK NIH HHS KO1 DK073272NIDDK NIH HHS SC1 DK087655NIMHD NIH HHS S21 MD000103NIMHD NIH HHS S21MD000103-NIH/NCMHD
6 · The paper itself

Abstract

aims/hypothesisTissue-specific amplification of glucocorticoid action through 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) affects the development of the metabolic syndrome. Hexose-6-phosphate dehydrogenase (H6PDH) mediates intracellular NADPH availability for 11β-HSD1 and depends on the glucose-6-phosphate transporter (G6PT). Little is known about the tissue-specific alterations of H6PDH and G6PT and their contributions to local glucocorticoid action in db/db mice.

methodsWe characterised the role of H6PDH and G6PT in pre-receptor metabolism of glucocorticoids by examining the production of the hepatic 11β-HSD1-H6PDH-G6PT system in db/db mice.

resultsWe observed that increased production of hepatic H6PDH in db/db mice was paralleled by upregulation of hepatic G6PT production and responded to elevated circulating levels of corticosterone. Treatment of db/db mice with the glucocorticoid antagonist RU486 markedly reduced production of both H6PDH and 11β-HSD1 and improved hyperglycaemia and insulin resistance. The reduction of H6PDH and 11β-HSD1 production by RU486 was accompanied by RU486-induced suppression of hepatic G6pt (also known as Slc37a4) mRNA. Incubation of mouse primary hepatocytes with corticosterone enhanced G6PT and H6PDH production with corresponding activation of 11β-HSD1 and PEPCK: effects that were blocked by RU486. Knockdown of H6pd by small interfering RNA showed effects comparable with those of RU486 for attenuating the corticosterone-induced H6PDH production and 11ß-HSD1 reductase activity in these intact cells. Addition of the G6PT inhibitor chlorogenic acid to primary hepatocytes suppressed H6PDH production. CONCLUSIONS/

interpretationThese findings suggest that increased hepatic H6PDH and G6PT production contribute to 11β-HSD1 upregulation of local glucocorticoid action that may be related to the development of type 2 diabetes.

Indexed as

11-beta-Hydroxysteroid Dehydrogenase Type 1AnimalsBlotting, WesternCarbohydrate DehydrogenasesCells, CulturedDiabetes Mellitus, Type 2HepatocytesMaleMiceMice, Inbred StrainsMonosaccharide Transport ProteinsPolymerase Chain Reaction11-beta-Hydroxysteroid Dehydrogenase Type 1Carbohydrate Dehydrogenasesgalactose-6-phosphate dehydrogenaseMonosaccharide Transport Proteins

Identifiers

PMID21052977
PMCPMC3795617
OpenAlexW1976089177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.